Patients with HT had a higher frequency of CD4+CXCR5+ICOShigh Tfh cells than those with GD or the nAITD controls (P = 0.0031, P < 0.0001) (Figure 2(d)). The gene discussed is CXCR5; the disease is hematocrit.